← Open Payments lookup

EUDALDO APONTE III: Open Payments

NPI 1720450166 · HIALEAH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$33,572 in 92 payments from 11 companies in 2025. Trend: 2023 $63,314 · 2024 $33,852 · 2025 $33,572

Speaker / faculty: $30,041Food & beverage: $2,448Travel & lodging: $753Consulting: $330
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.23$18,008
ABBVIE INC.30$14,440
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$273
Alkermes, Inc.7$264
Neurocrine BioSciences, Inc.8$214
Takeda Pharmaceuticals U.S.A., Inc.8$176
E.R. Squibb & Sons, L.L.C.3$67
Bausch Health US, LLC2$49
Axsome Therapeutics, Inc.2$40
Vanda Pharmaceuticals Inc.1$26

Products named: AUSTEDO XR, VRAYLAR, CAPLYTA, LYBALVI, INGREZZA, TRINTELLIX, COBENFY, APLENZIN.

Industry payments across FL — which companies pay providers there.